Canopy Growth Corp (CGC) Latest Filing Signal

Latest Filing: 10-Q  |  Filed Feb 6, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Canopy Growth Corp?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, Canopy Growth Corp's filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-2.73%
from filing date
60-Day Change
-9.82%
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Positive
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Canopy Growth Corp actually do?
Answer:
Canopy Growth Corporation is a global cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes. With core operations in Canada, Germany, and Australia, the company offers a portfolio of cannabis formats including dried flower, pre-rolled joints, oils, softgel capsules, edibles, and vapes, under various brands such as Tweed, 7ACRES, and Wana. Canopy Growth also leads in vaporization technology through its Storz & Bickel brand, which manufactures and sells medical and recreational vaporizers internationally. The company is strategically expanding its presence in the U.S. cannabis market through its significant non-controlling interest in Canopy USA, which holds investments in U.S. cannabis operators like Wana, Jetty, and Acreage.
Question:
What are Canopy Growth Corp's revenue drivers?
Answer:
Revenue is primarily driven by the sale of cannabis products in Canada for both adult-use and medical purposes, sales of vaporizers and accessories globally through Storz & Bickel, and international medical cannabis sales in markets like Europe and Australia.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required